Funded Tech Companies
Delinia
Delinia was a biopharmaceutical company, located in San Francisco. The company was acquired by Celgene.
Company Overview
Company Name
Delinia
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
953 Indiana Street
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Delinia is a biotechnology company developing novel therapeutics for the treatment of autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/26/2017
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Saurabh Saha
Chief Scientific Officer
Jeffrey Greve
VP - Bus. Development
Lijun Wu
Company Investors
- Atlas Accelerator (David Grayzel)
- Sofinnova Ventures (Henrijette Richter)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs